Role of 123-I -FP-Brain SPECT studies in clinical management of Parkinsonian Syndromes.

被引：0
|
作者：
Kotsalou, I. [1 ]
Karfis, I. [1 ]
Georgoulias, P. [2 ]
Aygoustatos, G. [3 ]
Zoumboulidis, A. [1 ]
Dimakopoulos, N. [1 ]
机构：
[1] NIMTS Hosp, Dept Nucl Med, Athens, Greece
[2] Larissa Univ, Dept Nucl Med, Larisa, Greece
[3] NIMTS Hosp, Dept Neurol, Athens, Greece
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2009年 / 36卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：S386 / S387
页数：2
相关论文
共 50 条
  • [41] The use of spect scintigraphy with I-123 ioflupane in differentiation of patients with parkinsonian syndromes and essential tremor
    Fistouris, D.
    Boussios, N.
    Karathanos, E.
    Tsairidis, D.
    Strataki, A.
    Apostolidou, V.
    Kyroudi, A.
    Zissimopoulos, A.
    FEBS JOURNAL, 2010, 277 : 77 - 77
  • [42] Affine registration of [123I]FP-CIT SPECT brain images
    Salas-Gonzalez, Diego
    Gorriz, Juan M.
    Ramirez, Javier
    Illan, Ignacio A.
    Padilla, Pablo
    Martinez-Murcia, Francisco J.
    Lang, Elmar W.
    INNOVATION IN MEDICINE AND HEALTHCARE 2014, 2014, 207 : 65 - 73
  • [43] Visual assessment of dopaminergic degeneration pattern in 123I-FP-CIT SPECT differentiates patients with atypical parkinsonian syndromes and idiopathic Parkinson's disease
    Deniz Kahraman
    Carsten Eggers
    Harald Schicha
    Lars Timmermann
    Matthias Schmidt
    Journal of Neurology, 2012, 259 : 251 - 260
  • [44] Combined 123I-FP-CIT SPECT semiquantitative and visual assessment in parkinsonian syndromes and dementia with Lewy bodies - response to Kawada et al.
    Nicastro, Nicolas
    Burkhard, Pierre R.
    Garibotto, Valentina
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2018, 392 : 126 - 127
  • [45] Correlation between 123I-IBZM SPECT and clinical diagnosis in parkinsonian syndrome
    Sainz-Esteban, A.
    Garcia-Talavera, P.
    Marco, J.
    Tola-Arribas, M.
    Ruiz, M.
    Gonzalez-Selma, M.
    Olmos, R.
    Gamazo, C.
    Munoz-Moreno, M.
    Gomez-Lopez, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 : S330 - S330
  • [46] The utility of the combination of a SPECT study with [123I]-FP-CIT of dopamine transporters and [123I]-MIBG myocardial scintigraphy in differentiating Parkinson disease from other degenerative parkinsonian syndromes
    Uyama, Naoto
    Otsuka, Hideki
    Shinya, Takayoshi
    Otomi, Yoichi
    Harada, Masafumi
    Sako, Wataru
    Izumi, Yuishin
    Kaji, Ryuji
    Watanabe, Yuya
    Takashi, Satoru
    Kunikane, Yamato
    NUCLEAR MEDICINE COMMUNICATIONS, 2017, 38 (06) : 487 - 492
  • [47] Clinical usefulness of 123I-FP-CIT SPECT imaging in vascular parkinsonism
    Garcia Solis, D.
    Benitez Rivero, S.
    Garcia Gomez, F. J.
    Marin, V. A.
    Huertas, I.
    Jesus, S.
    Ortiz, A. M.
    Carrillo, F.
    Carballo, M.
    Vazquez, R. J.
    Mir, P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 : S434 - S434
  • [48] Effect of Resolution Recovery on Quantification and Clinical Reporting of 123I FP-CIT Brain SPECT Images
    Fernandez, R. C.
    Sibley-Allen, C.
    Livieratos, L.
    Gnanasegaran, G.
    O'Doherty, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 : S264 - S265
  • [49] Clinical impact of dopamine transporter SPECT imaging using 123I-Ioflupane (DaTSCAN) in patients with clinically uncertain Parkinsonian syndromes
    Tolosa, E
    Catafau, AM
    MOVEMENT DISORDERS, 2002, 17 : S169 - S169
  • [50] 123I-FP-CIT SPECT Accurately Distinguishes Parkinsonian From Cerebellar Variant of Multiple System Atrophy
    Nicastro, Nicolas
    Garibotto, Valentina
    Burkhard, Pierre R.
    CLINICAL NUCLEAR MEDICINE, 2018, 43 (02) : e33 - e36
12345